Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Mycobacterium tuberculosis</i> subverts macrophage-mediated defense through exploitation of the Zn transporter ZIP8.

iScience·2026
Same author

Nonreciprocal scattering and implications for thermal emission control on a mid-infrared spatiotemporally modulated metasurface.

Nature communications·2026
Same author

Role of dual specificity phosphatase 1 in influencing inflammatory pathways in macrophages modulated by <i>Borrelia burgdorferi</i> lipoproteins.

Frontiers in immunology·2026
Same author

Human alveolar macrophage function is impaired in tuberculosis contacts with diabetes.

EBioMedicine·2025
Same author

NR4A nuclear receptor expression in human macrophages mediates apoptosis and controls Mycobacterium tuberculosis growth.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same author

RasGRP1 signaling is required for Vγ2+ thymocyte c-Maf expression and γδT17 lineage programming.

Journal of immunology (Baltimore, Md. : 1950)·2025
Same journal

<i>Porphyromonas gingivalis</i> sphingolipids affect early responses of THP-1 macrophages to outer membrane vesicles.

Infection and immunity·2026
Same journal

A genome-wide CRISPR screen defines host determinants of early <i>Brucella</i> infection in human macrophage-like cells.

Infection and immunity·2026
Same journal

Antiphospholipid antibodies in acute and post-treatment Lyme disease.

Infection and immunity·2026
Same journal

The cholesterol-dependent cytolysin promotes <i>Streptococcus</i> systemic spread and induces arachidonic acid accumulation-mediated lethality in a murine intraperitoneal infection model.

Infection and immunity·2026
Same journal

Phenotypic and genotypic analysis of <i>Candida albicans</i> vaginal isolates reveals that <i>ECE1</i> expression underpins pathogenicity.

Infection and immunity·2026
Same journal

<i>Staphylococcus aureus</i> pore-forming toxins differentially shape disease severity in experimental endophthalmitis.

Infection and immunity·2026
See all related articles

Related Experiment Video

Updated: May 20, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

Innate immune gene polymorphisms in tuberculosis.

Abul K Azad1, Wolfgang Sadee, Larry S Schlesinger

  • 1Department of Microbial Infection and Immunity, Center for Microbial Interface Biology, The Ohio State University, Columbus, Ohio, USA.

Infection and Immunity
|July 25, 2012
PubMed
Summary
This summary is machine-generated.

Genetic variations in innate immune genes influence tuberculosis (TB) susceptibility. Understanding these host genetic factors, including polymorphisms in macrophage receptors and cytokines, is crucial for developing novel TB control strategies.

More Related Videos

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish
07:00

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish

Published on: October 8, 2018

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Related Experiment Videos

Last Updated: May 20, 2026

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
07:42

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1

Published on: February 28, 2025

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish
07:00

Modeling Tuberculosis in Mycobacterium marinum Infected Adult Zebrafish

Published on: October 8, 2018

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
10:10

A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection

Published on: October 5, 2015

Area of Science:

  • Immunogenetics
  • Infectious Disease Epidemiology
  • Genomics

Background:

  • Tuberculosis (TB) remains a major global infectious disease mortality cause.
  • Host genetic factors, specifically polymorphisms, are increasingly recognized as key determinants of TB susceptibility.
  • Innumerable candidate gene and case-control studies have identified numerous genetic variants linked to TB pathogenesis.

Purpose of the Study:

  • To review current understanding of polymorphisms in host innate immune genes associated with TB.
  • To discuss specific gene families involved in innate immunity and their relation to TB susceptibility.
  • To explore the impact of evolutionary pressures and study design limitations on observed genetic associations.

Main Methods:

  • Comprehensive literature review of studies investigating host genetic polymorphisms and TB susceptibility.
  • Analysis of polymorphisms in genes encoding macrophage receptors, soluble C-type lectins, cytokines, chemokines, and other innate immune molecules.
  • Discussion of genomic technologies for elucidating genetic variant functions and evolutionary impacts.

Main Results:

  • Polymorphisms in genes such as Toll-like receptors (TLRs), vitamin D nuclear receptor (VDR), and tumor necrosis factor (TNF) are variably associated with TB susceptibility across populations.
  • Observed variability in genetic associations is likely due to evolutionary selection pressures and limitations in study design and functional analysis.
  • Specific examples of implicated genes include mannose receptor (MR), DC-SIGN, Dectin-1, NOD1/2, CD14, P2X7, SP-A/D, MBL, IL-1β/6/10/12/18, IL-8, MCP-1, RANTES, CXCL10, iNOS, and SLC11A1.

Conclusions:

  • Host genetic variations in innate immune genes play a significant role in TB susceptibility.
  • Understanding the functional effects and evolutionary context of these polymorphisms is essential for accurate association studies.
  • Advanced genomic technologies offer promising avenues for novel TB control strategies by unraveling host-pathogen evolutionary dynamics.